NKTR
NEKTAR THERAPEUTICS
NASDAQ · Healthcare · Biotechnology · US
$36.64
+2.40%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 31.47x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.39x
- Price / sales
- 22.92x
- Price / cash flow
- -5.35x
Enterprise value
- Enterprise value
- $702.6M
- EV / sales
- 12.87x
- EV / EBITDA
- -5.23x
- EV / EBIT
- -5.35x
- Market cap
- $1.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026